NIH-funded research Fellowship grant

Investigating how COVID-19 affects brain inflammation in older adults

Official title: Exploring the role of hyper-phagocytic microglia and SYK signaling in the aged hippocampus during COVID-19

Funded at University of Virginia · NIH-11016938 · Data updated 2026-11-12

This study is looking at how COVID-19 might affect the brains of older people, especially how inflammation could lead to memory problems or Alzheimer's, by examining changes in the brains of older mice that got the virus.

More COVID-19 research and trials

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionUniversity of Virginia
NIH-funded
Lab location1 site (Charlottesville, United States)
Project startMarch 1, 2024
Project endFebruary 28, 2027
Funding year2025
Award (this year)$38,183
NIH project number5F31NS135897-02
Project IDNIH-11016938 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are older adults who have experienced COVID-19 and are showing signs of cognitive decline or neurological symptoms.

Less likely to help

Patients who are younger or have not been infected with COVID-19 are unlikely to benefit from this research.

What this research studies

This research explores the impact of COVID-19 on the brains of older individuals, particularly focusing on inflammation and its potential link to cognitive decline and Alzheimer's disease. By studying aged mice infected with a mouse-adapted strain of SARS-CoV-2, the researchers aim to understand how hyper-phagocytic microglia, a type of immune cell in the brain, respond to the infection. The study will analyze changes in the hippocampus, a critical area for memory and learning, to uncover mechanisms that may contribute to neurological issues following COVID-19. The findings could provide insights into how systemic inflammation from infections like COVID-19 can exacerbate age-related cognitive decline.

Why it matters

Potential benefit: If successful, this research could lead to better understanding and treatment options for cognitive decline in older adults following COVID-19.

How similar studies have gone: Other research has indicated that inflammation plays a significant role in cognitive decline, suggesting that this approach may yield valuable insights.

Where this research is happening

  • University of Virginia
    Charlottesville, United States
    Active

Researchers

  • Principal investigator: Natale, Nick — University of Virginia
  • Study coordinator: Natale, Nick

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.